BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu B, Staren E, Iwamura T, Appert H, Howard J. Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines. World J Gastroenterol 2001; 7(6): 855-859 [PMID: 11854916 DOI: 10.3748/wjg.v7.i6.855]
URL: https://www.wjgnet.com/1007-9327/full/v7/i6/855.htm
Number Citing Articles
1
Shinzaburo Noguchi. Predictive factors for response to docetaxel in human breast cancers. Cancer Science 2006; 97(9) doi: 10.1111/j.1349-7006.2006.00265.x
2
Qingming Luo, Xingde Li, Ying Gu, Yuguo Tang, A. Zyubin, A. Lavrova, S. Babak, V. Malaschenko, A. Borisova, N. Opryshko. Childhood lymphoblastic leukemia adverse drug reactions: study of risk factors and therapy prognosis by optical methods . Optics in Health Care and Biomedical Optics VII 2016; 10024 doi: 10.1117/12.2246024
3
S. Cereda, M. Reni. Weekly Docetaxel as Salvage Therapy in Patients with Gemcitabine-Refractory Metastatic Pancreatic Cancer. Journal of Chemotherapy 2008; 20(4) doi: 10.1179/joc.2008.20.4.509
4
Min Zheng, Lian-Xin Liu, An-Long Zhu, Shu-Yi Qi, Hong-Chi Jiang, Zhu-Ying Xiao. <i>K-ras</i> gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic masses. World Journal of Gastroenterology 2003; 9(1): 188-191 doi: 10.3748/wjg.v9.i1.188
5
Sabine Danzinger, Martin Filipits. Biomarker – der Weg zur individualisierten Chemotherapie beim nicht-kleinzelligen Bronchialkarzinom. Wiener Medizinische Wochenschrift 2007; 157(21-22) doi: 10.1007/s10354-007-0483-x
6
Maria Kavallaris. Microtubules and resistance to tubulin-binding agents. Nature Reviews Cancer 2010; 10(3) doi: 10.1038/nrc2803
7
Martin Filipits, Robert Pirker. Predictive markers in the adjuvant therapy of non-small cell lung cancer. Lung Cancer 2011; 74(3) doi: 10.1016/j.lungcan.2011.06.005
8
9
10
Li-Hua Chen, Xue-Song Liu, Wen-Yong Wang, Wei-Ning Han, Bo-Rong Pan, Bo-Quan Jin. Localization of TRAIL/TRAILR in fetal pancreas. World Journal of Gastroenterology 2003; 9(2): 334-337 doi: 10.3748/wjg.v9.i2.334
11
Jia-Yin Yang, Hua-You Luo, Qi-Yuan Lin, Zi-Ming Liu, Lu-Nan Yan, Ping Lin, Jie Zhang, Shong Lei. Subcellular daunorubicin distribution and its relation to multidrug resistance phenotype in drug-resistant cell line SMMC-7721/R. World Journal of Gastroenterology 2002; 8(4): 644-649 doi: 10.3748/wjg.v8.i4.644
12
Joshua A. McCarroll, Maria Kavallaris. Cytoskeleton and Human Disease. 2012;  doi: 10.1007/978-1-61779-788-0_12
13
Rajan Sharma Bhattarai, Virender Kumar, Svetlana Romanova, Jitender Bariwal, Hao Chen, Shanshan Deng, Vijaya R. Bhatt, Tatiana Bronich, Wei Li, Ram I. Mahato. Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer. Journal of Controlled Release 2021; 329 doi: 10.1016/j.jconrel.2020.09.052
14
Berardi Rossana, Scartozzi Mario, Freddari Federica, Squadroni Michela, Santinelli Alfredo, Bearzi Italo, Fabris Guidalberto, Cascinu Stefano. Biliary tract cancers: Molecular profiling as a tool for treatment decisions. A literature review. Cancer Treatment Reviews 2006; 32(5) doi: 10.1016/j.ctrv.2006.03.003
15
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, Charles R. Ashby, Yehuda G. Assaraf, Zhe-Sheng Chen, Abhijit Dey. Therapeutic strategies to overcome taxane resistance in cancer. Drug Resistance Updates 2021; 55 doi: 10.1016/j.drup.2021.100754
16
17
Mihoko A. Tame, Anna G. Manjón, Daria Belokhvostova, Jonne A. Raaijmakers, René H. Medema. TUBB3 overexpression has a negligible effect on the sensitivity to taxol in cultured cell lines. Oncotarget 2017; 8(42) doi: 10.18632/oncotarget.17740
18
Xue-Liang Guo, Geng-Jin Lin, Hong Zhao, Yong Gao, Li-Ping Qian, San-Rong Xu, Li-Na Fu, Qing Xu, Jie-Jun Wang. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World Journal of Gastroenterology 2003; 9(9): 1995-1998 doi: 10.3748/wjg.v9.i9.1995
19
J Torin Huzil, Richard F Ludueña, Jack Tuszynski. Comparative modelling of human β tubulin isotypes and implications for drug binding. Nanotechnology 2006; 17(4) doi: 10.1088/0957-4484/17/4/014
20
Zhong-Qiu Wang, Jie-Shou Li, Guang-Ming Lu, Xin-Hua Zhang, Zi-Qian Chen, Kui Meng. Correlation of CT enhancement, tumor angiogenesis and pathologic grading of pancreatic carcinoma. World Journal of Gastroenterology 2003; 9(9): 2100-2104 doi: 10.3748/wjg.v9.i9.2100
21
D. Calligaris, P. Verdier-Pinard, F. Devred, C. Villard, D. Braguer, Daniel Lafitte. Microtubule targeting agents: from biophysics to proteomics. Cellular and Molecular Life Sciences 2010; 67(7) doi: 10.1007/s00018-009-0245-6
22
Juan Deng, Giulia Lencioni, Aldo Pastore, Adam E. Frampton, Dongmei Deng, Elisa Giovannetti. Fluid shear stress enhances pancreatic cancer motility through YAP activation. Clinical Epigenetics 2026; 18(1) doi: 10.1186/s13148-026-02163-4